Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Smeland, Sigbjørn, Bielack, Stefan S., Whelan, Jeremy, Bernstein, Mark, Hogendoorn, Pancras, Krailo, Mark D., Gorlick, Richard, Janeway, Katherine A. +44 more·2019·European Journal of Cancer

DOI 10.1016/j.ejca.2018.11.027

Cited by (720)

Items 301–400 of 720

Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses
Hidetatsu Outani, Masachika Ikegami, Yoshinori Imura, Sho Nakai, Haruna Takami, Yuki Kotani, Akitomo Inoue, Seiji Okada · 2024 · International Journal of Clinical Oncology
Osteosarcoma of the mobile spine: a single-institution experience of 32 patients
Jordan O. Gasho, Vineet Desai, Santiago A. Lozano‐Calderón, G. Petur Nielsen, Yin Pun Hung, Joseph Hasbrouck Schwab, Daniel G. Tobert · 2025 · The Spine Journal
Osteosarcoma in Japan: report from the bone and soft tissue tumor registry 2006–2022
Koichi Ogura, Hirotaka Kawano, Shoji Shimose, Koji Hiraoka, Akihiko Matsumine, Akira Kawai · 2025 · Japanese Journal of Clinical Oncology
Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment
Lei He, Pamela Habibović, Sabine van Rijt · 2025 · Journal of Controlled Release
Radiomics for predicting sensitivity to neoadjuvant chemotherapy in osteosarcoma: current status and advances
Panhong Zhang, Weitao Yao, Zhehuang Li, Yichao Fan, Xinhui Du, Bangmin Wang, Fan Zhang, Jingyu Hou, Qilong Su · 2025 · Oncology Reviews
pH/ROS-responsive magnesium scaffold functionalized via hydrazone bonds for localized postoperative bone tumor therapy
Yanfeng Ding, Xing Fen, Song Chen, Yiqing Zhang, Qingjiang Pang · 2025 · Colloids and Surfaces B Biointerfaces
The Outcome of Children With Malignant Bone Tumors: A Single-Center Experience
Mohammadreza Bordbar, Ali Sarfaraz, Sezaneh Haghpanah, Omid Reza Zekavat, Soheila Zareifar, Tahereh Zarei · 2021 · Global Pediatric Health
Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
Yibo Ma, Shuo Zheng, Mingjun Xu, Changjian Chen, Hongtao He · 2023 · Stem Cells International
CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion
Ning Wang, Yong Chen, Jie Wu · 2023 · Oncology Letters
RETRACTED: Exploring the role of lactylation‐related genes in osteosarcoma: A deep dive into prognostic significance and therapeutic potential
Jingdong Sun, Yong Li, Rui Chen, Yi Xie, Jie Wei, Binbin Li · 2023 · Environmental Toxicology · Retracted
Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4/PI3K/AKT signaling
Yang Zi Jiang, Yemei Gao, Xin Li, Fangming He, Yang Liu, Renxian Wang · 2023 · Journal of Orthopaedic Surgery and Research
The importance of basic and translational research in caring for children with malignant solid tumors in Latin America
María Belén Cancela, Milagros Dinardi, Rosario Aschero, Santiago Zugbi, Guillermo Luis Chantada, Lorena Baroni, Paula S. Schaiquevich · 2024 · Revista Panamericana de Salud Pública
Relative Wash-In Rate in Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a New Prognostic Biomarker for Event-Free Survival in 82 Patients with Osteosarcoma: A Multicenter Study
Gijsbert M. Kalisvaart, Richard E. Evenhuis, Willem Grootjans, Thomas Van Den Berghe, Martijn Callens, Judith V.M.G. Bovée, David Creytens, Hans A. J. Gelderblom, Frank M. Speetjens, Lore Lapeire et al. · 2024 · Cancers
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma
Shiyong Xin, Yanwei Zhang, Zhenhua Zhang, Ziyao Li, Xianchao Sun, Xiang Liu, Liang Jin, Weiyi Li, Chaozhi Tang, Wangli Mei et al. · 2024 · Cancer Gene Therapy
Comprehensive analysis of the clinical significance and molecular mechanism of T-box transcription factor 3 in osteosarcoma
Yu-Nan Man, Hua Xu, Pei-Jun Chen, Yu Sun, Maolin He · 2024 · Journal of Cancer
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial
Qinglian Tang, Xin‐Ke Zhang, Xiaojun Zhu, Huaiyuan Xu, Guohui Song, Jinchang Lu, Hao Wu, Chuangzhong Deng, Fei Ai, Yingchun Zhang et al. · 2024 · Cancer Medicine
A detoxified TLR4 agonist inhibits tumour growth and lung metastasis of osteosarcoma by promoting CD8+ cytotoxic lymphocyte infiltration
Ryunosuke Oyama, Akira Nabeshima, Makoto Endo, Alexey Novikov, Toshifumi Fujiwara, Capucine Phelip, Nobuhiko Yokoyama, Yoshinao Oda, Martine Caroff, Yoshihiro Matsumoto et al. · 2025 · BJC Reports
Improving oncological outcomes for pelvic bone sarcomas: Is it possible?
Minna Laitinen, Vineet John Kurisunkal, Michael Parry, Guy Vernon Morris, Jonathan Daniel Stevenson, Lee Marcus Jeys · 2025 · European Journal of Surgical Oncology
Interdisciplinary management of skull base surgery
René Marcel Rothweiler, Marc Christian Metzger, Pit Jacob Voss, Jürgen Beck, Rainer Schmelzeisen · 2021 · Journal of Oral Biology and Craniofacial Research
Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma
Marta Spreafico, Francesca Ieva, Francesca Arlati, Federico Capello, Federico Fatone, Filippo Fedeli, Gianmarco Genalti, Jakob Anninga, Hans A. J. Gelderblom, Marta F. Fiocco · 2021 · BMJ Open
Intralesional margin after excision of a high‐grade osteosarcoma: Is it a catastrophe?
Panagiotis Tsagkozis, Czar Louie Gaston, Emelie Styring, Felix Haglund, Robert John Grimer · 2022 · Journal of Surgical Oncology
CD146 is closely associated with the prognosis and molecular features of osteosarcoma: Guidance for personalized clinical treatment
Jingkun Wang, Zhonghan Wu, Meige Zheng, Shuisheng Yu, Xin Zhang, XinZhong Xu · 2022 · Frontiers in Genetics
Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients
Shuvadeep Ganguly, Archana Sasi, Shah Alam Khan, Venkatesan Sampath Kumar, Love Kapoor, Mehar Chand Sharma, Asit Ranjan Mridha, Adarsh Wamanrao Barwad, Sanjay Prayagraj Thulkar, Deepam Pushpam et al. · 2023 · Frontiers in Oncology
LncRNA SNHG25 Predicts Poor Prognosis and Promotes Progression in Osteosarcoma via the miR-497-5p/SOX4 Axis
Ningjun Wan, Qiang Liu, Jiandang Shi, Siliang Wang · 2023 · Combinatorial Chemistry & High Throughput Screening
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data
Marta Spreafico, Audinga‐Dea Hazewinkel, Hans A. J. Gelderblom, Marta F. Fiocco · 2024 · Current Oncology
Does the Duration of Primary and First Revision Surgery Influence the Probability of First and Subsequent Implant Failures after Extremity Sarcoma Resection and Megaprosthetic Reconstruction?
Christoph Theil, Kristian Nikolaus Schneider, Georg Gosheger, Ralf Dieckmann, Niklas Deventer, Jendrik Hardes, Tom Schmidt-Braekling, Dimosthenis Andreou · 2021 · Cancers
Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol
Amaranto Suárez-Mattos, Federico Arroyave, Ana M. Infante, Carlos Narváez, Camilo Soto, Luis Carlos Gómez Mier, Javier Amaya-Nieto · 2022 · Boletín Médico del Hospital Infantil de México
miR-30 inhibits the progression of osteosarcoma by targeting MTA1.
Aiqing Zhao, Yanbin Zhao, Wei Qi Feng, Zhenqun Zhao, Wanlin Liu, Na Wang, Huiqin Xue, Lishuan Wu, Shuxia Cui, Rui Bai · 2022 · PubMed Central
Clinical significance of indeterminate pulmonary nodules on the survival of 364 patients with nonmetastatic, high‐grade, localized osteosarcoma: A 12‐year retrospective cohort study
Chenliang Zhou, Yiyun Wang, Guowei Qian, Hongtao Li, Wenxi Yu, Zan Shen, Shuier Zheng, Yonggang Wang · 2020 · Journal of Surgical Oncology
Thymoquinone Augments Methotrexate-Induced Apoptosis on Osteosarcoma Cells
Narjes Sanapour, Faezeh Malakoti, Darioush Shanebandi, Niloufar Targhazeh, Bahman Yousefi, Jafar Soleimanpour, Maryam Majidinia · 2022 · Drug Research
Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials
Damon R. Reed, Asmin Tulpule, Jonathan L. Metts, Matteo Maria Trucco, Mark Robertson‐Tessi, Tara J. O’Donohue, Fiorella Iglesias Cardenas, Michael S. Isakoff, Audrey Mauguen, Neerav Narendra Shukla et al. · 2024 · Journal of Clinical Oncology
Pediatric cancer—pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
Consolato Maria Sergi · 2024 · Discover Oncology
Quantitative and Morphology-Based Deep Convolutional Neural Network Approaches for Osteosarcoma Survival Prediction in the Neoadjuvant and Metastatic Settings
Nicolas Coudray, Michael A. Occidental, Jose Gabriel Mantilla, Adalberto Claudio Quiros, Ke Yuan, Ján Balko, Aristotelis Tsirigos, George Jour · 2024 · Clinical Cancer Research
CAFs exosomal miR-21-5p suppresses ferroptosis and promotes proliferation and migration in osteosarcoma
Xiaoying Niu, Wen Tian, Yuanmeng Ke, Yifan Li, Xinxin Zhang · 2025 · Cancer Cell International
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS)
Stefan Bielack, Dimosthenis Andreou, Daniel Baumhoer, Claudia Blattmann, Godehard Friedel, Birgit Fröhlich, Semi Harrabi, Leo Kager, Thekla v. Kalle, Torsten Keßler et al. · 2026 · Journal of Cancer Research and Clinical Oncology
sB7-H3 as a prognostic biomarker in osteosarcoma: insights into clinical outcomes
Yuwei Zhao, Kunkun Sun, Yiyang Yu, Jie Xu, Yuhang Wang, Chenchen Yang, Hengyue Ma, Yuanfeng Zhou, Tingting Ren, Xiaodong Tang et al. · 2026 · Scientific Reports
Fluorescence guided surgery using indocyanine green for pulmonary osteosarcoma metastasectomy in pediatric patients: A feasibility study
Bernadette Jeremiasse, Caroline C. C. Hulsker, Ceder H. van den Bosch, Myrthe A. D. Buser, Cornelis P. van der Ven, Guus M.J. Bökkerink, Marc H. W. A. Wijnen, Alida F. W. van der Steeg · 2023 · EJC Paediatric Oncology
Postoperative infection and bone sarcoma survival: systematic review of the role of infection in bone sarcoma prognosis
Sean W. Dooley, Matthew F. Gong, Luke Carlson, Andrew J. Frear, Jonathan Brendan Mandell, Aaron Zheng, Sumail S. Bhogal, Karen Elizabeth Schoedel, Kurt Richard Weiss · 2023 · Annals of Joint
Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
Kerri D. Becktell, Yan Chen, Yutaka Yasui, Rachel Phelan, Gregory T. Armstrong, Michael Paul Link, Kevin Charles Oeffinger, Claire Frances Snyder, Najat C. Daw, Brent R. Weil et al. · 2024 · Pediatric Blood & Cancer
The Critical Role of Stereotactic Body Radiation Therapy in Multimodal Treatment of Lung Metastasis from Bone and Soft Tissue Sarcomas
Alessandra Longhi, Andrea Marrari, Cecilia Tetta, Anna Parmeggiani, Orlando Parise, Cristina Ferrari, Fabrizio Salvi, Giovanni Piero Frezza · 2024 · Cancers
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small‐Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma
Stefano Zanardi, Silvia Sabattini, Federica Rossi, Matteo Rossanese, Paolo Buracco, Vincenzo Montinaro, Marina Aralla, Alfredo Dentini, Elisa Pizzi, Enrico Volpe et al. · 2025 · Veterinary and Comparative Oncology
Machine learning reveals novel targets for both glioblastoma and osteosarcoma
Nan Li, Max Ward, Muniba Bashir, Yunpeng Cao, Amitava Datta, Zhaoyu Li, Shuang Zhang · 2025 · Heliyon
IGFBP3 modulation of tumor pathogenesis and cell signaling pathways (Review)
Yanzi Zhang, Xin Lv · 2025 · Oncology Letters
Construction and Validation of an Autophagy-Related Prognostic Model for Osteosarcoma Patients
Qian Hu, Ting Lei, Pengfei Lei, Yihe Hu · 2021 · Journal of Oncology
Enhancing osteosarcoma therapy through aluminium hydroxide nanosheets-enabled macrophage modulation
Min Cheng, Yi Jiang, Ying Wang, Yilun Wu, Yishen Zhu · 2023 · International Journal of Pharmaceutics
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura et al. · 2024 · Cancer Gene Therapy
Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF
Sjahjenny Mustokoweni, Ferdiansyah Mahyudin, Rosy Setiawati, Dian Nugrahenny, Mohamad Hidayat, Handono Kalim, Karyono Mintaroem, Loeki Enggar Fitri, Pancras C.W. Hogendoorn · 2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Identification of a novel cellular senescence-related lncRNA signature for prognosis and immune response in osteosarcoma
Honglin Wu, Chuanbao Deng, Xiaoqing Zheng, Yongxiong Huang, Chong Chen, Honglin Gu · 2024 · Translational Cancer Research
Immunohistochemical study of histone protein 3 modification in pediatric osteosarcoma identifies reduced H3K27me3 as a marker of poor treatment response
Sebastian Kondratowski, Danielle Cohen, Rebecca J. Deyell, Ash Sandhu, Jonathan W. Bush · 2024 · PLoS ONE
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis
Lenka Anne Skaidrite Ilcisin, Clement Ma, Katherine A. Janeway, Steven G. DuBois, David Stephen Shulman · 2020 · Pediatric Blood & Cancer
Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt/mTOR signaling
Lu Lu, Yuhai Wang, Jian Chen, Li Ye, Qingyang Liang, Feng Li, Chuanchuan Zhen, Kegong Xie · 2021 · Oncology Letters
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
Javier Muñoz-García, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer, Denis Cochonneau, Jérôme Amiaud, Marie‐Françoise Heymann, Dominique Heymann, Frédéric Lézot · 2022 · Cancers
Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?
Yongsung Kim, Jong Woong Park, Hwan Seong Cho, Woo Young Jang, Ilkyu Han, Han‐Soo Kim · 2023 · Clinical Orthopaedics and Related Research
Progression before local control in osteosarcoma: Outcome and prognosis‐predictive factors
Hadeel Halalsheh, Shrouq Amer, Iyad Yasin Sultan · 2023 · Pediatric Blood & Cancer
The heterogeneity and drug resistance of malignant cells and intercellular communication of microenvironment in osteosarcoma: Based on single‐cell analysis
Haonan Ma, Xiaoyu Wang, Jiayi Zhao, Jiayi Wang, Qian Li, Jinrong Liang, Xiaomin Ding, Yawen Zhang, Yan Zhou, Haiyan Hu · 2023 · Clinical and Translational Discovery
Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.
Wen-I Chang, Joshua N. Honeyman, Jun Zhang, Claire Lin, Aditi Sharma, Lanlan Zhou, Janice Oliveira, Nikos Tapinos, Rishi Ramesh Lulla, Varun V. Prabhu et al. · 2023 · PubMed Central
Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma
Yang Liu, Tova Corbascio, Jintian Huang, Jacob Engellau, Lars Lidgren, Magnus Tägil, Deepak Bushan Raina · 2024 · Journal of Functional Biomaterials
The Role of Sociodemographics in Pediatric, Adolescent and Young Adult Osteosarcoma: A Population Based Study
Connor D. Fritz, Anthony V. Basta, Jonathan Benjamin Gill, Valerae Olive Lewis, Justin E. Bird, Mary Thomas Austin · 2025 · Journal of Pediatric Surgery
The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma
Guisen Lai, Xinyi Zhao, Yuanquan Chen, Tianwei Xie, Zepeng Su, Jiajie Lin, Keng Chen, Keng Chen · 2025 · International Immunopharmacology
PDK1, associated with glycolytic metabolism, is a potential prognostic biomarker in osteosarcoma
Jin Qi, Sihang Liu, Xufeng Hu, Xikang Luo, Y. Y. Wang · 2025 · PLoS ONE
A review of immunotherapy for bone tumors
Chenwen Wang, Zixiong Chen, Haokun Mo, Jiang Wang, Wei Zhou · 2025 · Frontiers in Immunology
Sarcoma: Cardiovascular and Oncologic Considerations
Daniel S. Lefler, Elise F. Nassif, Anju Nohria, Mark Agulnik, Jacquelyn N. Crane, Michael G. Fradley · 2025 · JACC CardioOncology
Stage at Diagnosis and International Survival Variation in Childhood Tumors in the BENCHISTA Study
Laura Botta, Fabio Didoné, Angela Lopez-Cortes, Adela Cañete-Nieto, Emmanuel Désandes, Lisa Lyngsie Hjalgrim, Zsuzsanna Jakab, Charles A. Stiller, Bernward Zeller, Simon Bailey et al. · 2026 · JAMA Network Open
New biological insights into osteosarcoma—lessons from single cell sequencing studies
Julia I. Zehenter, Leo Kager, Sebastian K. Eder, Sabine Taschner‐Mandl, Snežana Hinić · 2026 · Cancer and Metastasis Reviews
Lung and bone metastases patterns in limb osteosarcoma: Surgical treatment of primary site improves overall survival
Binbin Liu, Liyuan Tang, Ningning Peng, Liguo Wang · 2023 · Medicine
Significance of the Pretreatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting the Response to Neoadjuvant Chemotherapy and Survival Rates in Extremity Osteosarcoma: A Multicentre Prospective Study
Amir Mohammad Arefpour, Maryam Garousi, Ahmad Foroughi, Saeed Hosseini, Mohadeseh Shahin, Seyed Alireza Javadinia · 2023 · Cancer Investigation
A Retrospective Study of 291 Patients With Head and Neck Sarcomas: Treatment, Outcomes, and Prognostic Factors
Ramsen Ghasan Hikmet, Tejs Ehlers Klug, S.D. Gade, Birgitte Sandfeld‐Paulsen, Ninna Aggerholm Pedersen · 2024 · Clinical Oncology
Therapeutic impacts of GNE‑477‑loaded H2O2 stimulus‑responsive dodecanoic acid‑phenylborate ester‑dextran polymeric micelles on osteosarcoma
Songmu Pan, Zhuan Zou, Xiaofeng Zhou, Jiyong Wei, Huijiang Liu, Zhongyi Su, Gui Liao, Guangyu Huang, Zonggui Huang, Yi Xu et al. · 2024 · International Journal of Molecular Medicine
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)
Stefan Bielack, Vanessa L. Mettmann, Stefanie Hecker‐Nolting, Arndt Borkhardt, Jendrik Hardes, Leo Kager, Thekla v. Kalle, Matthias Kevric, Ewa Kościelniak, Christian Peter Kratz et al. · 2024 · Pediatric Blood & Cancer
C-terminal binding protein-2 triggers CYR61-induced metastatic dissemination of osteosarcoma in a non-hypoxic microenvironment
Laura Di Patria, Nadia Habel, Robert Olaso, Romain Fernandes, Catherine Brenner, Bojana Stefanovska, Olivia Fromigué · 2025 · Journal of Experimental & Clinical Cancer Research
Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma
Roelof van Ewijk, Laura S. Hiemcke‐Jiwa, Jayne Y. Hehir‐Kwa, Nathalie Gaspar, Lianne Haveman, Uta E. Flucke, Rana Dandis, Marc C van Tuil, Claudia Y. Janda, Michiel A. J. van de Sande et al. · 2025 · JCO Precision Oncology
Advances in the role of miRNAs in the occurrence and development of osteosarcoma
Guanyu Zhang, Yiran Li, Jiasheng Xu, Zhenfang Xiong · 2020 · Open Medicine
Prognostic factors and treatment of relapsed osteosarcoma: A monocentric Tunisian retrospective study
Wala Ben Kridis, Sana Ennouri, Souhir Khmiri, Hassib Keskes, Jamel Daoud, Afef Khanfir · 2022 · Archives de Pédiatrie
How to confront the high prevalence of pulmonary micro nodules (PMNs) in osteosarcoma patients?
Zhenyu Cai, Jie Xu, Xin Sun, Ranxin Zhang, Lu Xie, Jichuan Wang, Xiaodong Tang, Rongli Yang, Wei Guo · 2022 · International Orthopaedics
What has changed in the last 25 years in osteosarcoma treatment? A single center experience
Eda Ataseven, Zeynep Burak, Dündar Sabah, Başak Doğanavşargıl, Mehmet Argın, Burçin Keçeci, İpek Tamsel, Hüseyin Kaya, Şebnem Önen Göktepe, Mehmet Kantar · 2023 · The Turkish Journal of Pediatrics
Preoperative Predictors of Early Mortality Risk in People with Osteosarcoma of the Extremities Treated with Standard Therapy
Ke Tian, Peng-ju Li, Yan Zhang · 2022 · Cancer Management and Research
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
Julius Cornelis Heemelaar, Jeroen Alphons Janson, Jerry Braun, Frank M. Speetjens, Michiel A. J. van de Sande, Juan de Villiers Hugo, Daniela Q.C.M. Barge‐Schaapveld, Saskia L.M.A. Beeres, Laurens F. Tops, Hans A. J. Gelderblom et al. · 2022 · Cardio-Oncology
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group
Nicole Bodmer, Stefanie Hecker‐Nolting, Godehard Friedel, Claudia Blattmann, Leo Kager, Torsten Keßler, Matthias Kevric, Thomas Kühne, Vanessa L. Mettmann, Peter Müller‐Abt et al. · 2023 · Cancer
Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma
Sameer Sadashiv Apte, Eyal Mor, Catherine Mitchell, David E. Gyorki · 2023 · Current Oncology
Improving Outcomes for Adolescents and Young Adults With Sarcoma: A Focus on Cancer Care Delivery
John Andrew Livingston · 2019 · Journal of Oncology Practice
The prognostic value of baseline EARL standardized FDG PET indices in pediatric and adolescent high-grade osteosarcoma
Roelof van Ewijk, Rana Dandis, Janna Rodewijk, Bart de Keizer, Simone A. J. ter Horst, Michiel A. J. van de Sande, Lizz van der Heijden, Johannes H. M. Merks, Lianne Haveman, Arthur J. A. T. Braat · 2025 · European Radiology
Development and validation of a predictive score for chemoresistance in high-grade osteosarcoma at baseline
Thanat Kanthawang, Nuttaya Pattamapaspong, Jongkolnee Settakorn, Pattira Boonsri, Pimpisa Teeyakasem, Phichayut Phinyo, Dumnoensun Pruksakorn · 2025 · Frontiers in Medicine
Neutrophil elastase promotes low molecular weight cyclin E1 formation to accelerate osteosarcoma proliferation
Jiuhui Xu, Qianyu Shi, Fanwei Zeng, Tingting Ren, Ran Wei, Xiaodong Tang · 2025 · Frontiers in Immunology
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R. Reed, Katherine A. Janeway, Charles Gene Minard, David C. Hall, Brian D. Crompton, Alexander J. Lazar, Wei‐Lien Wang, Rebecca J. Zylber, Alejandro Contreras, Giselle Carrero et al. · 2025 · JCO oncology advances.
Pan-cancer analysis of role of LOXL4 and experiment validation in osteosarcoma
Wenjie Chen, Fujie Xie, Jie Lv, Dixi Huang, Ronghao Zhong, Zhijia Wen, Jiangsen Sun, Shaowei Zheng, Weile Liu, Haobo Zhong et al. · 2025 · Discover Oncology
A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma
Benjamin Baffour Gyau, Tsz-Kwong Chris Man · 2025 · International Journal of Molecular Sciences
Outcomes and survival rates of childhood osteosarcoma in Iran, A report from MAHAK Pediatric Cancer Treatment and Research Center, from 2007 to 2020
Azim Mehrvar, Narjes Mehrvar, Yasaman Sadeghi, Maryam Tashvighi · 2023 · Journal of Cancer Research and Therapeutics
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells
Anna Josefine von Ofen, Uwe Thiel, Jennifer Eck, Hendrik Gassmann, Melanie Thiede, Julia Hauer, Per Sonne Holm, Sebastian Johannes Schober · 2024 · Frontiers in Oncology
Osteosarcomas in retinoblastoma-survivors. A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)
Stefan Bielack, Daniel Baumhoer, Stefanie Hecker‐Nolting, Simone Hettmer, Leo Kager, Petra Ketteler, Matthias Kevric, Christian Peter Kratz, Thomas Kühne, Vanessa L. Mettmann et al. · 2024 · EJC Paediatric Oncology
A GAD1 inhibitor suppresses osteosarcoma growth through the Wnt/β-catenin signaling pathway
Changchun Jian, Ben Wang, Hai Mou, Ye Zhang, Chaohua Yang, Qiu Huang, Yunsheng Ou · 2024 · Heliyon
Bone Radiation-Induced Sarcomas: Outcomes Based on Histology and Surgical Treatment
Maria L. Inchaustegui, Felipe Larios, J. Buteau, Marcos R. Gonzalez, Juan A. Pretell-Mazzini · 2024 · JBJS Reviews
Novel intravenous formulation for radiosensitization in osteosarcoma treatment
Haitao Zeng, Huixiong Feng, Chong Zhang, Zhe Kang, Jianping Wu, Xingqi Zhao, Anfei Huang, Yanyang Xu, Yufeng Huang, Hongwen Xu et al. · 2025 · Materials Today Bio
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group
Pascaline Boudou, Elodie Martin, Emmanuelle Kempf, Nicolas Penel, Maud Toulmonde, Emmanuelle Bompas, Florence Duffaud, Nelly Firmin, François Bertucci, Jean‐Emmanuel Kurtz et al. · 2021 · International Journal of Cancer
Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion
Anu K. Kaskinen, Emmi Helle, Jaana I. Pihkala, Timo Jahnukainen, Jukka A. Kanerva, Mikko Ilari Mäyränpää, Karl Lemström, Ilkka P. Mattila, Tiina H. Ojala · 2021 · JACC Case Reports
Prognostic impact of pulmonary nodules diagnosed at initial presentation in patients with osteosarcoma
Sabine Irtan, Jean Donadieu, Hélène Pacquement, Marie‐Dominique Tabone, Sophie Piperno-Neumann, Nathalie Gaspar, Marta Jimenez, M. Larroquet, Sabine Sarnacki, Cécile Cellier et al. · 2022 · Pediatric Blood & Cancer
Early Complications after Limb Salvage Procedures: Prospective Cross Sectional Study
Ziad Ali, Javeria Saeed, Masood Umer · 2022 · International Journal of Surgery Oncology
Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
Junsong Zhang, Runsang Pan, Xiaobin Tian · 2023 · Frontiers in Oncology
Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma
Kristopher J. Jackson, Camille D. Sullivan, Melissa N. Zimel, Rosanna L. Wustrack, on behalf of the PARITY Investigators · 2023 · Journal of Bone and Joint Surgery
Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors
Kalevi Kairemo, Mohamed Alaa Gouda, Lars Buschhorn, Adam Wahida, Homer A. Macapinlac, Peter Meade Anderson, Vivek Subbiah · 2023 · ESMO Open
Impact of delay of local control in nonmetastatic extremity primary osteosarcoma
Hadeel Halalsheh, Taleb Ismael, Mohammad Boheisi, Ahmad M. Shehadeh, Iyad Yasin Sultan · 2023 · Pediatric Blood & Cancer